2 months ago
PVLA
AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 15%
#795 out of 5254 analysts
Average Return
+13.07%
Win Rate
64%27 out of 42
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | +92.85% | $45.05 | $86.88 | 2024-12-10 - 2025-12-09 | Strong Buy |
Nurix Therapeutics IncNRIX | +68.37% | $10.40 | $17.51 | 2025-10-23 - 2026-04-17 | Strong Buy |
Perspective Therapeutics IncCATX | +67.33% | $2.51 | $4.20 | 2026-01-13 - 2026-04-17 | Strong Buy |
Palvella Therapeutics IncPVLA | +58.74% | $81.90 | $130.01 | 2026-01-29 - 2026-04-17 | Strong Buy |
Kymera Therapeutics IncKYMR | +57.19% | $55.80 | $87.71 | 2025-10-22 - 2026-04-17 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
4 months ago
NRIX
4 months ago
KYMR
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascentage Pharma Group InternationalAAPG | 2 | Strong Buy | $48.00 | +75.18% | Reiterates | 8 days ago |
Verastem IncVSTM | 2 | Strong Buy | $19.00 | +188.75% | Reiterates | 10 days ago |
Aardvark Therapeutics IncAARD | 4 | Strong Buy | $9.00 | +72.08% | Reiterates | a month ago |
Arvinas IncARVN | 3 | Strong Buy | $16.00 | +45.45% | Maintains | a month ago |
Perspective Therapeutics IncCATX | 4 | Strong Buy | $14.00 | +233.33% | Reiterates | a month ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $8.00 | +381.93% | Assumes | a month ago |
Immunitybio IncIBRX | 1 | Strong Buy | $13.00 | +68.83% | Assumes | a month ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $42.00 | +41.70% | Assumes | a month ago |
Kymera Therapeutics IncKYMR | 6 | Strong Buy | $134.00 | +52.78% | Maintains | 2 months ago |
Palvella Therapeutics IncPVLA | 5 | Strong Buy | $215.00 | +65.37% | Maintains | 2 months ago |
Monopar TherapeuticsMNPR | 6 | Strong Buy | $104.00 | +84.99% | Reiterates | 2 months ago |
Nurix Therapeutics IncNRIX | 5 | Strong Buy | $30.00 | +71.33% | Reiterates | 3 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $28.00 | +16.62% | Initiates Coverage On | 3 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $11.00 | +107.94% | Initiates Coverage On | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.